A RANDOMISED clinical trial has found that low-dose semaglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist, reduces alcohol craving and some measures of alcohol consumption in adults with alcohol use disorder (AUD), supporting the need for larger trials to explore its potential as a treatment
"There are additional complex metabolites that others are looking at, so we're potentially opening a whole new interest into how cancer cells acquire nutrients and how to block that activity
Note that peppermint oil may worsen symptoms in those with gastro-oesophageal reflux disease (GORD)
We use the data entered only for the purpose of using the respective offer or service for which you have registered
Dietary cysteine and other amino acids and stroke incidence in women Patten A.R., et al
People with kidney disease, hypothyroidism, or seizures should avoid L-carnitine without medical clearance